4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000899243-19-006186
President sold 85,220 shares at an average $40.40 ($3,443,037)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Novak Rodger President | 2019-03-01 | Sale | −8,693 | $40.01 | $347,796 | 1,024,534 | D |
| Novak Rodger President | 2019-03-04 | Sale | −64,115 | $40.24 | $2,580,186 | 960,419 | D |
| Novak Rodger President | 2019-03-04 | Sale | −8,912 | $41.29 | $367,949 | 951,507 | D |
| Novak Rodger President | 2019-03-04 | Sale | −3,500 | $42.03 | $147,105 | 948,007 | D |
| Open-market sales · 85,220 sh · avg $40.40 · $3,443,037 | |||||||
Loading xslF345X03/doc4.xml…